NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders
Version 2 2024-06-05, 11:23
Version 1 2021-05-11, 15:53
journal contribution
posted on 2024-06-05, 11:23 authored by C Markulev, PD McGorry, B Nelson, HP Yuen, M Schaefer, Alison YungAlison Yung, A Thompson, G Berger, N Mossaheb, M Schlögelhofer, S Smesny, L de Haan, A Riecher-Rössler, M Nordentoft, EYH Chen, S Verma, I Hickie, GP AmmingerNEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders
History
Journal
Early Intervention in PsychiatryVolume
11Pagination
418-428Location
AustraliaPublisher DOI
ISSN
1751-7885eISSN
1751-7893Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
5Publisher
WILEYUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicinePsychiatryneuroprotectionomega-3 polyunsaturated fatty acidpsychosisrandomized controlled trialultra high riskANTIPSYCHOTIC TREATMENT1ST-EPISODE PSYCHOSISINDICATED PREVENTIONUNTREATED PSYCHOSISMENTAL-HEALTHRATING-SCALEFOLLOW-UPINTERVENTIONSDURATIONMETAANALYSIS3202 Clinical sciences3209 Neurosciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC